Brean Murray initiates coverage on Obagi Medical Products (Nasdaq: OMPI) with Buy. Price target $10

Brean analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE